What is IRIDEX's operating income?

IRIDEX's total operating income in 2026 was -$2.57 million, based on the following breakdown: Total Gross Profit: $19.23 million Total Operating Expenses: $21.80 million

IRIDEX (IRIX) Financials

$0.95 -0.10 (-9.43%)

Closing price 07/16/2026 04:00 PM Eastern

Extended Trading

$0.94 -0.01 (-0.63%)

As of 06:08 AM Eastern

Compare

Annual Income Statements for IRIDEX

This table shows IRIDEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2021	2022	2023	2024	2026
Period end date	1/3/2015	1/2/2016	12/31/2016	12/30/2017	12/29/2018	12/28/2019	1/1/2022	12/31/2022	12/30/2023	12/28/2024	1/3/2026
Net Income / (Loss) Attributable to Common Shareholders	10	0.47	-12	-13	-13	-8.81	-5.23	-7.55	-9.57	-8.91	-4.44
Consolidated Net Income / (Loss)	10	0.47	-12	-13	-13	-8.81	-5.23	-7.55	-9.57	-8.91	-4.44
Net Income / (Loss) Continuing Operations	10	0.47	-12	-13	-13	-8.81	-5.23	-7.55	-9.57	-8.91	-4.44
Total Pre-Tax Income	1.33	0.29	-2.66	-13	-13	-8.77	-5.19	-7.48	-9.48	-8.84	-4.38
Total Operating Income	2.59	0.29	-2.57	-13	-13	-8.97	-7.53	-7.54	-10	-8.30	-2.57
Total Gross Profit	21	20	21	16	17	18	23	25	22	20	19
Total Revenue	43	42	46	42	43	43	54	57	52	49	53
Operating Revenue	43	42	46	42	43	43	54	57	52	49	53
Total Cost of Revenue	21	22	25	26	25	26	31	32	30	29	33
Operating Cost of Revenue	21	22	25	26	25	26	31	32	30	29	33
Total Operating Expenses	19	20	23	28	30	27	30	33	32	28	22
Selling, General & Admin Expense	6.03	5.55	7.64	8.78	9.55	8.38	8.86	7.56	8.75	9.78	7.73
Marketing Expense	8.16	8.90	10	15	17	15	15	18	16	13	10
Research & Development Expense	4.63	5.21	5.37	5.21	4.01	3.68	6.87	7.18	6.83	5.45	3.67
Total Other Income / (Expense), net	-1.26	0.00	-0.09	-0.11	0.09	0.21	2.35	0.06	0.53	-0.54	-1.81
Other Income / (Expense), net	-1.26	0.00	-0.09	-0.11	0.09	0.21	2.35	0.06	0.53	-0.54	-1.81
Income Tax Expense	-8.71	-0.18	9.06	-0.13	0.04	0.05	0.04	0.07	0.09	0.07	0.06
Basic Earnings per Share	$1.01	$0.05	($1.15)	($1.11)	($1.05)	($0.64)	($0.34)	($0.47)	($0.59)	($0.54)	($0.26)
Weighted Average Basic Shares Outstanding	9.89M	9.96M	10.17M	11.56M	12.20M	13.71M	15.42M	15.94M	16.13M	16.44M	16.93M
Diluted Earnings per Share	$0.97	$0.05	($1.15)	($1.11)	($1.05)	($0.64)	($0.34)	($0.47)	($0.59)	($0.54)	($0.26)
Weighted Average Diluted Shares Outstanding	10.36M	10.13M	10.17M	11.56M	12.20M	13.71M	15.42M	15.94M	16.13M	16.44M	16.93M
Weighted Average Basic & Diluted Shares Outstanding	9.90M	9.50M	11.52M	11.63M	13.63M	13.79M	15.88M	16.01M	16.25M	16.79M	17.31M

This table shows IRIDEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	4/4/2026
Net Income / (Loss) Attributable to Common Shareholders	-1.75	-2.96	-3.46	-2.68	-1.93	-0.83	-1.69	-0.99	-1.57	-0.52
Consolidated Net Income / (Loss)	-1.75	-2.96	-3.46	-2.68	-1.93	-0.83	-1.69	-0.99	-1.57	-0.52
Net Income / (Loss) Continuing Operations	-1.75	-2.96	-3.46	-2.68	-1.93	-0.83	-1.69	-0.99	-1.57	-0.52
Total Pre-Tax Income	-1.75	-2.90	-3.43	-2.66	-1.92	-0.84	-1.67	-0.97	-1.57	-0.47
Total Operating Income	-1.69	-3.08	-3.29	-2.64	-1.87	-0.50	-0.21	-0.94	-1.41	-0.32
Total Gross Profit	5.62	4.89	4.46	5.14	4.32	5.59	5.06	4.68	4.01	4.74
Total Revenue	13	12	12	13	12	13	12	14	12	12
Operating Revenue	13	12	12	13	12	13	12	14	12	12
Total Cost of Revenue	7.23	7.57	7.30	7.50	7.26	7.11	6.84	8.89	8.47	7.06
Operating Cost of Revenue	7.23	7.57	7.30	7.50	7.26	7.11	6.84	8.89	8.47	7.06
Total Operating Expenses	7.31	7.97	7.75	7.77	6.19	6.09	5.26	5.62	5.42	5.07
Selling, General & Admin Expense	1.95	2.41	2.47	2.79	2.25	2.28	1.93	2.22	1.80	1.62
Marketing Expense	3.82	3.87	3.75	3.49	2.65	2.70	2.45	2.54	2.66	2.54
Research & Development Expense	1.54	1.69	1.54	1.50	1.30	1.11	0.88	0.87	0.97	0.91
Total Other Income / (Expense), net	-0.06	0.18	-0.13	-0.02	-0.05	-0.34	-1.47	-0.03	-0.16	-0.14
Other Income / (Expense), net	-0.06	0.18	-0.13	-0.02	-0.05	-0.34	-1.47	-0.03	-0.16	-0.14
Income Tax Expense	0.01	0.06	0.04	0.02	0.02	-0.01	0.01	0.02	0.00	0.06
Basic Earnings per Share	($0.11)	($0.18)	($0.21)	($0.16)	($0.12)	($0.05)	($0.10)	($0.06)	($0.09)	($0.03)
Weighted Average Basic Shares Outstanding	16.23M	16.13M	16.25M	16.29M	16.58M	16.44M	16.73M	16.79M	17.01M	17.31M
Diluted Earnings per Share	($0.11)	($0.18)	($0.21)	($0.16)	($0.12)	($0.05)	($0.10)	($0.06)	($0.09)	($0.03)
Weighted Average Diluted Shares Outstanding	16.23M	16.13M	16.25M	16.29M	16.58M	16.44M	16.73M	16.79M	17.01M	17.31M
Weighted Average Basic & Diluted Shares Outstanding	16.25M	16.25M	16.25M	16.51M	16.64M	16.79M	16.79M	16.99M	17.19M	17.41M

This table details how cash moves in and out of IRIDEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2021	2022	2023	2024	2026
Period end date	1/3/2015	1/2/2016	12/31/2016	12/30/2017	12/29/2018	12/28/2019	1/1/2022	12/31/2022	12/30/2023	12/28/2024	1/3/2026
Net Change in Cash & Equivalents	-0.14	-3.31	14	-2.04	-0.51	-8.58	12	-9.93	-6.89	-4.65	3.64
Net Cash From Operating Activities	4.01	-0.59	-0.14	-3.57	-10	-7.91	8.22	-9.52	-6.75	-7.29	-2.12
Net Cash From Continuing Operating Activities	4.01	-0.59	-0.14	-3.57	-10	-7.91	8.22	-9.52	-6.75	-7.29	-2.12
Net Income / (Loss) Continuing Operations	10	0.47	-12	-13	-13	-8.81	-5.23	-7.55	-9.57	-8.91	-4.44
Consolidated Net Income / (Loss)	10	0.47	-12	-13	-13	-8.81	-5.23	-7.55	-9.57	-8.91	-4.44
Depreciation Expense	0.42	0.52	0.65	0.86	0.81	0.69	0.80	0.49	1.10	0.58	0.52
Amortization Expense	-	-	-	-	-	-	0.91	0.90	0.93	1.17	1.25
Non-Cash Adjustments To Reconcile Net Income	1.02	0.96	2.06	1.78	1.81	1.73	-0.20	1.20	1.86	1.62	2.44
Changes in Operating Assets and Liabilities, net	-7.47	-2.55	8.86	6.66	0.17	-1.52	12	-4.55	-1.07	-1.75	-1.89
Net Cash From Investing Activities	-1.03	-1.30	-1.47	-0.78	-0.83	-0.51	-5.56	-0.29	-0.11	-0.01	-0.14
Net Cash From Continuing Investing Activities	-1.03	-1.30	-1.47	-0.78	-0.83	-0.51	-5.56	-0.29	-0.11	-0.01	-0.14
Purchase of Property, Plant & Equipment	-0.57	-0.88	-1.06	-0.58	-0.44	-0.13	-0.21	-0.29	-0.11	-0.01	-0.14
Net Cash From Financing Activities	-3.13	-1.42	15	2.31	10	-0.16	9.47	-0.07	-0.01	2.61	5.96
Net Cash From Continuing Financing Activities	-3.13	-1.42	15	2.31	10	-0.16	9.47	-0.07	-0.01	2.61	5.96
Repayment of Debt	-	-	-	-	-	-	-	-	0.00	-0.71	-3.96
Issuance of Debt	-	-	-	-	-	0.00	0.00	-	0.00	3.37	4.00
Issuance of Preferred Equity	-	-	-	-	-	-	-	-	-	0.00	6.00
Other Financing Activities, net	1.54	0.42	0.61	0.04	-0.10	-0.16	-0.41	-0.07	-0.01	-0.05	-0.08
Effect of Exchange Rate Changes	-	-	-	-	-	-	0.10	-0.05	-0.03	0.05	-0.07
Cash Income Taxes Paid	0.04	0.03	0.02	0.01	0.01	0.01	0.02	0.07	0.05	0.02	-0.02

This table details how cash moves in and out of IRIDEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	4/4/2026
Net Change in Cash & Equivalents	-1.84	-0.95	-1.62	-1.31	-0.25	-1.47	4.86	-0.47	-1.21	-1.43
Net Cash From Operating Activities	-1.78	-0.98	-1.65	-1.33	-3.07	-1.24	-1.15	-0.40	-1.16	-1.34
Net Cash From Continuing Operating Activities	-1.78	-0.98	-1.65	-1.33	-3.07	-1.24	-1.15	-0.40	-1.16	-1.34
Net Income / (Loss) Continuing Operations	-1.75	-2.96	-3.46	-2.68	-1.93	-0.83	-1.69	-0.99	-1.57	-0.52
Consolidated Net Income / (Loss)	-1.75	-2.96	-3.46	-2.68	-1.93	-0.83	-1.69	-0.99	-1.57	-0.52
Depreciation Expense	0.11	0.62	0.17	0.14	0.14	0.14	0.14	0.13	0.11	0.10
Amortization Expense	0.25	0.16	0.23	0.23	0.27	0.44	0.38	0.28	0.29	0.30
Non-Cash Adjustments To Reconcile Net Income	0.24	0.63	0.48	0.73	0.07	0.35	1.60	0.03	0.69	0.40
Changes in Operating Assets and Liabilities, net	-0.62	0.57	0.94	0.26	-1.62	-1.32	-1.58	0.16	-0.67	-1.61
Net Cash From Investing Activities	-0.08	0.03	-0.00	-	-0.00	-0.01	-0.01	-0.01	-0.01	-0.10
Net Cash From Continuing Investing Activities	-0.08	0.03	-0.00	-	-0.00	-0.01	-0.01	-0.01	-0.01	-0.10
Purchase of Property, Plant & Equipment	-0.08	0.03	-0.00	-	-0.00	-0.01	-0.01	-0.01	-0.01	-0.10
Net Cash From Financing Activities	-0.02	0.05	0.00	-	2.82	-0.22	6.04	-0.01	-0.03	-0.00
Net Cash From Continuing Financing Activities	-0.02	0.05	0.00	-	2.82	-0.22	6.04	-0.01	-0.03	-0.00
Repayment of Debt	-	-	0.00	-	-0.49	-0.22	-3.96	-	-	0.00
Issuance of Debt	-	-	0.00	-	3.37	-	4.00	-	-	0.00
Issuance of Preferred Equity	-	-	0.00	-	-	-	6.00	-	-	0.00
Other Financing Activities, net	-0.02	0.05	-	-	-0.05	-	0.00	-	-0.03	-0.00
Effect of Exchange Rate Changes	0.05	-0.05	-	-	-	-0.01	-0.02	-	-	0.00
Cash Income Taxes Paid	0.00	-0.00	0.00	0.02	-0.00	-0.00	0.02	-	-	0.00

This table presents IRIDEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2021	2022	2023	2024	2026
Period end date	1/3/2015	1/2/2016	12/31/2016	12/30/2017	12/29/2018	12/28/2019	1/1/2022	12/31/2022	12/30/2023	12/28/2024	1/3/2026
Total Assets	42	42	48	42	42	35	49	42	34	29	29
Total Current Assets	33	31	46	39	40	31	42	36	27	24	25
Cash & Equivalents	13	10.00	24	22	21	13	24	14	7.03	2.39	6.03
Accounts Receivable	8.34	9.28	10	7.86	9.08	9.32	9.72	6.23	6.73	5.95	7.61
Inventories, net	9.12	11	12	9.38	8.79	8.17	7.61	11	9.91	11	7.88
Prepaid Expenses	0.51	0.39	0.45	0.50	0.55	0.40	1.07	1.47	0.86	1.96	1.80
Other Current Assets	-	-	-	-	-	-	-	3.54	2.93	2.44	1.93
Plant, Property, & Equipment, net	0.74	1.10	1.53	1.40	1.22	0.73	0.43	0.46	0.35	0.12	0.06
Total Noncurrent Assets	8.19	9.95	0.75	0.79	0.83	3.53	6.01	6.06	6.64	5.46	3.84
Goodwill	0.53	0.53	0.53	0.53	0.53	0.53	0.97	0.97	0.97	0.97	0.97
Intangible Assets	0.28	0.27	0.13	0.12	0.10	0.08	2.21	1.98	1.64	1.31	0.98
Other Noncurrent Operating Assets	0.22	0.16	0.08	0.14	0.20	2.92	2.84	3.12	4.03	3.19	1.89
Total Liabilities & Shareholders' Equity	42	42	48	42	42	35	49	42	34	29	29
Total Liabilities	8.08	8.14	8.98	11	12	12	25	25	25	27	24
Total Current Liabilities	7.04	7.43	8.17	10	11	9.78	13	12	13	17	13
Accounts Payable	1.76	2.22	1.99	1.72	2.52	2.59	3.40	3.86	4.50	6.99	5.39
Accrued Expenses	2.24	2.33	2.45	3.69	3.39	1.92	1.68	1.72	2.00	0.48	0.61
Current Deferred Revenue	1.18	1.31	1.38	2.52	1.64	1.45	2.36	2.41	2.40	2.18	2.16
Current Employee Benefit Liabilities	1.86	1.57	2.35	2.46	2.96	2.40	3.19	2.45	1.62	1.67	2.34
Other Current Liabilities	-	-	-	-	-	1.41	2.03	2.02	2.46	3.52	2.72
Total Noncurrent Liabilities	1.04	0.70	0.82	0.73	1.21	2.33	13	13	12	10	11
Long-Term Debt	-	-	-	-	-	0.00	-	-	0.00	1.00	3.74
Noncurrent Deferred Revenue	-	-	-	-	0.59	0.36	11	12	10	8.35	6.80
Other Noncurrent Operating Liabilities	1.04	0.70	0.82	0.73	0.62	1.97	1.81	0.86	1.92	1.13	0.49
Commitments & Contingencies	0.00	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	34	34	39	31	30	23	23	17	9.52	2.10	4.92
Total Preferred & Common Equity	34	34	39	31	30	23	23	17	9.52	2.10	4.92
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.00
Total Common Equity	34	34	39	31	30	23	23	17	9.52	2.10	-1.08
Common Stock	39	38	55	60	72	73	85	87	89	90	91
Retained Earnings	-4.88	-4.41	-16	-29	-42	-51	-62	-70	-79	-88	-92
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	0.07	0.08	0.05	-0.02	-0.05	0.05	-0.01

This table presents IRIDEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025	4/4/2026
Total Assets	35	34	31	30	34	32	28	28
Total Current Assets	27	28	25	24	29	27	24	25
Cash & Equivalents	7.98	5.42	4.11	3.86	7.24	6.78	5.57	4.60
Accounts Receivable	6.11	6.53	6.27	5.95	6.68	7.14	7.13	6.84
Inventories, net	10	11	11	11	10	8.44	7.30	9.33
Prepaid Expenses	1.13	2.01	1.73	1.76	2.36	1.63	1.66	2.25
Other Current Assets	2.01	2.62	1.77	1.83	2.71	2.89	2.40	1.57
Plant, Property, & Equipment, net	0.52	0.27	0.21	0.16	0.08	0.04	0.02	0.14
Total Noncurrent Assets	7.08	6.25	6.03	5.66	5.03	4.68	4.26	3.55
Goodwill	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97
Intangible Assets	1.73	1.56	1.48	1.39	1.22	1.14	1.06	0.90
Other Noncurrent Operating Assets	4.39	3.73	3.59	3.30	2.84	2.57	2.24	1.68
Total Liabilities & Shareholders' Equity	35	34	31	30	34	32	28	28
Total Liabilities	23	28	27	28	27	26	24	24
Total Current Liabilities	10	16	16	16	15	14	12	13
Accounts Payable	2.61	7.68	7.77	6.20	6.05	5.31	4.41	5.75
Accrued Expenses	1.42	1.11	0.87	1.01	0.97	0.58	0.59	0.69
Current Deferred Revenue	2.24	2.45	2.29	2.34	2.09	2.27	2.21	2.04
Current Employee Benefit Liabilities	2.20	2.26	2.14	1.84	2.02	1.86	1.93	1.72
Other Current Liabilities	1.88	2.57	3.08	3.15	3.83	3.68	3.25	2.63
Total Noncurrent Liabilities	13	12	11	12	12	12	11	11
Long-Term Debt	-	-	-	1.44	3.64	3.68	3.71	3.77
Noncurrent Deferred Revenue	10	9.71	9.26	8.76	7.97	7.59	7.21	6.42
Other Noncurrent Operating Liabilities	2.07	1.83	1.60	1.48	0.83	0.56	0.37	0.53
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	12	6.49	4.25	2.62	0.85	6.06	4.68	4.73
Total Preferred & Common Equity	12	6.49	4.25	2.62	0.85	6.06	4.68	4.73
Preferred Stock	0.00	0.00	0.00	0.00	-	6.00	6.00	6.00
Total Common Equity	12	6.49	4.25	2.62	0.85	0.06	-1.32	-1.27
Common Stock	88	89	89	90	91	91	91	92
Retained Earnings	-76	-83	-85	-87	-90	-91	-92	-93
Accumulated Other Comprehensive Income / (Loss)	-0.02	-0.02	0.00	0.00	0.03	-0.01	-0.01	-0.01

This table displays calculated financial ratios and metrics derived from IRIDEX's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2021	2022	2023	2024	2026
Period end date	1/3/2015	1/2/2016	12/31/2016	12/30/2017	12/29/2018	12/28/2019	1/1/2022	12/31/2022	12/30/2023	12/28/2024	1/3/2026
DEI Shares Outstanding	9,841,749.00	9,945,820.00	10,148,110.00	11,579,817.00	13,594,140.00	13,781,752.00	15,865,734.00	15,989,622.00	16,247,813.00	16,636,380.00	17,189,981.00
DEI Adjusted Shares Outstanding	9,841,749.00	9,945,820.00	10,148,110.00	11,579,817.00	13,594,140.00	13,781,752.00	15,865,734.00	15,989,622.00	16,247,813.00	16,636,380.00	17,189,981.00
DEI Earnings Per Adjusted Shares Outstanding	1.02	0.05	-1.15	-1.11	-0.94	-0.64	-0.33	-0.47	-0.59	-0.54	-0.26
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.86%	-2.47%	10.54%	-9.89%	2.42%	1.99%	0.00%	5.69%	-8.96%	-6.17%	0.00%
EBITDA Growth	-36.34%	-53.60%	-346.99%	-504.43%	1.40%	32.51%	0.00%	-75.38%	-22.14%	4.81%	0.00%
EBIT Growth	-41.11%	-78.15%	-1,012.71%	-389.27%	1.69%	31.39%	0.00%	-44.30%	-26.70%	6.73%	0.00%
NOPAT Growth	650.73%	-97.59%	-482.74%	-402.46%	0.16%	30.26%	0.00%	-0.12%	-32.68%	17.04%	0.00%
Net Income Growth	349.93%	-95.28%	-2,571.10%	-9.85%	0.42%	31.22%	0.00%	-44.44%	-26.81%	6.90%	0.00%
EPS Growth	340.91%	-94.85%	-2,400.00%	3.48%	5.41%	39.05%	0.00%	-38.24%	-25.53%	8.47%	0.00%
Operating Cash Flow Growth	423.34%	-114.77%	75.72%	-2,375.69%	-181.21%	21.07%	0.00%	-215.85%	29.14%	-8.01%	0.00%
Free Cash Flow Firm Growth	3,695.51%	-124.33%	332.35%	-137.38%	-269.68%	15.55%	0.00%	0.00%	32.35%	6.67%	0.00%
Invested Capital Growth	64.65%	15.95%	-34.95%	-42.81%	-0.54%	14.66%	0.00%	698.37%	-24.81%	-1.61%	0.00%
Revenue Q/Q Growth	2.83%	0.81%	0.91%	-5.21%	2.96%	0.68%	0.00%	-0.10%	-5.01%	0.49%	0.00%
EBITDA Q/Q Growth	-17.40%	75.22%	-223.87%	-53.13%	17.09%	13.49%	0.00%	25.27%	-20.62%	20.76%	0.00%
EBIT Q/Q Growth	-21.09%	865.79%	-118.78%	-48.12%	16.22%	12.90%	0.00%	14.74%	-22.89%	18.90%	0.00%
NOPAT Q/Q Growth	804.07%	-14.41%	-156.50%	-47.36%	15.21%	12.59%	0.00%	11.57%	-20.05%	23.71%	0.00%
Net Income Q/Q Growth	495.37%	-94.61%	-2,446.30%	30.55%	15.21%	12.81%	0.00%	14.65%	-23.36%	19.26%	0.00%
EPS Q/Q Growth	470.59%	-93.98%	-3,733.33%	35.84%	18.60%	12.33%	0.00%	14.55%	-22.92%	19.40%	0.00%
Operating Cash Flow Q/Q Growth	93.91%	-159.30%	-227.27%	-19.91%	-12.58%	19.05%	0.00%	1.53%	8.31%	-3.69%	0.00%
Free Cash Flow Firm Q/Q Growth	1,925.40%	70.56%	311.36%	-137.28%	-25.19%	19.00%	-100.00%	-8.37%	19.68%	-14.16%	0.00%
Invested Capital Q/Q Growth	62.44%	4.80%	-38.29%	-28.63%	-1.32%	-8.95%	-124.80%	49.12%	-39.06%	60.95%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.00%	47.78%	45.15%	37.27%	41.01%	41.29%	42.36%	44.53%	42.04%	40.07%	36.50%
EBITDA Margin	4.09%	1.95%	-4.35%	-29.18%	-28.09%	-18.59%	-6.45%	-10.70%	-14.36%	-14.57%	-4.95%
Operating Margin	6.04%	0.69%	-5.56%	-30.99%	-30.21%	-20.66%	-13.98%	-13.24%	-19.29%	-17.06%	-4.88%
EBIT Margin	3.11%	0.70%	-5.75%	-31.24%	-29.99%	-20.17%	-9.62%	-13.13%	-18.28%	-18.17%	-8.32%
Profit (Net Income) Margin	23.45%	1.14%	-25.38%	-30.94%	-30.08%	-20.28%	-9.69%	-13.25%	-18.45%	-18.31%	-8.42%
Tax Burden Percent	753.60%	162.89%	441.00%	99.02%	100.29%	100.55%	100.77%	100.87%	100.95%	100.77%	101.30%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	-653.60%	-62.89%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	118.72%	2.13%	-9.18%	-74.47%	-102.46%	-66.76%	0.00%	-383.12%	-241.67%	-235.47%	-68.46%
ROIC Less NNEP Spread (ROIC-NNEP)	189.44%	2.08%	49.60%	-57.55%	-84.72%	-51.80%	0.00%	-371.11%	-217.19%	-142.74%	46.56%
Return on Net Nonoperating Assets (RNNOA)	-85.03%	-0.72%	-22.97%	37.54%	60.10%	33.29%	0.00%	345.88%	170.13%	82.10%	-21.69%
Return on Equity (ROE)	33.69%	1.41%	-32.16%	-36.93%	-42.37%	-33.47%	-22.43%	-37.24%	-71.54%	-153.37%	-90.15%
Cash Return on Invested Capital (CROIC)	69.86%	-12.65%	33.16%	-20.01%	-101.92%	-80.42%	0.00%	-276.26%	-213.35%	-233.85%	0.00%
Operating Return on Assets (OROA)	3.53%	0.70%	-5.90%	-28.95%	-30.67%	-22.92%	-10.65%	-16.45%	-24.71%	-27.82%	-15.03%
Return on Assets (ROA)	26.59%	1.13%	-26.04%	-28.66%	-30.76%	-23.05%	-10.73%	-16.59%	-24.95%	-28.03%	-15.22%
Return on Common Equity (ROCE)	33.69%	1.41%	-32.16%	-36.93%	-42.37%	-33.47%	-22.43%	-37.24%	-71.54%	-153.37%	19.74%
Return on Equity Simple (ROE_SIMPLE)	29.75%	1.41%	-29.91%	-42.16%	-42.77%	-38.82%	-22.43%	-43.80%	-100.50%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	19	0.47	-1.80	-9.02	-9.01	-6.28	-5.27	-5.28	-7.00	-5.81	-1.80
NOPAT Margin	45.54%	1.12%	-3.89%	-21.69%	-21.14%	-14.46%	-9.78%	-9.27%	-13.51%	-11.94%	-3.42%
Net Nonoperating Expense Percent (NNEP)	-70.72%	0.04%	-58.78%	-16.92%	-17.74%	-14.96%	0.20%	-12.01%	-24.48%	-92.73%	-115.02%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-73.57%	-120.19%	-20.79%
Cost of Revenue to Revenue	50.00%	52.22%	54.85%	62.73%	58.99%	58.71%	57.64%	55.47%	57.96%	59.93%	63.50%
SG&A Expenses to Revenue	14.09%	13.29%	16.55%	21.11%	22.42%	19.29%	16.44%	13.26%	16.87%	20.09%	14.68%
R&D to Revenue	10.81%	12.49%	11.62%	12.52%	9.40%	8.47%	12.74%	12.59%	13.17%	11.20%	6.96%
Operating Expenses to Revenue	43.95%	47.09%	50.70%	68.26%	71.22%	61.94%	56.33%	57.77%	61.34%	57.13%	41.38%
Earnings before Interest and Taxes (EBIT)	1.33	0.29	-2.66	-13	-13	-8.77	-5.19	-7.48	-9.48	-8.84	-4.38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.75	0.81	-2.01	-12	-12	-8.08	-3.48	-6.10	-7.45	-7.09	-2.61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.51	2.74	3.64	2.89	2.02	1.43	4.16	1.87	4.79	13.25	0.00
Price to Tangible Book Value (P/TBV)	2.57	2.81	3.71	2.95	2.06	1.47	4.82	2.25	6.60	0.00	0.00
Price to Revenue (P/Rev)	1.98	2.21	3.09	2.12	1.42	0.75	1.80	0.56	0.88	0.57	0.38
Price to Earnings (P/E)	8.44	194.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	11.85%	0.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.50	3.48	7.72	7.55	4.48	1.96	0.00	5.51	15.52	11.49	9.06
Enterprise Value to Revenue (EV/Rev)	1.67	1.97	2.58	1.60	0.92	0.45	1.36	0.32	0.74	0.58	0.45
Enterprise Value to EBITDA (EV/EBITDA)	40.77	101.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	53.63	283.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	3.66	175.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.80	0.00	0.00	0.00	0.00	0.00	8.89	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	6.23	0.00	18.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.31	0.76
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.76
Financial Leverage	-0.45	-0.35	-0.46	-0.65	-0.71	-0.64	-1.02	-0.93	-0.78	-0.58	-0.47
Leverage Ratio	1.27	1.24	1.24	1.29	1.38	1.45	2.09	2.24	2.87	5.47	5.92
Compound Leverage Factor	1.27	1.24	1.24	1.29	1.38	1.45	2.09	2.24	2.87	5.47	5.92
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	56.63%	43.14%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	35.86%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	20.77%	43.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	69.31%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	43.37%	-12.45%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.39	-1.43
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.05	0.88
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.14	-1.43
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.47	-2.08
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.06	1.27
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.17	-2.08
Altman Z-Score	8.00	8.36	10.78	4.59	2.54	0.70	1.99	-0.11	-1.01	-2.66	-2.13
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	121.90%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.67	4.14	5.62	3.80	3.77	3.12	3.34	2.87	2.12	1.42	1.91
Quick Ratio	3.07	2.59	4.13	2.85	2.88	2.25	2.65	1.62	1.06	0.50	1.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	11	-2.79	6.48	-2.42	-8.96	-7.57	0.00	-9.14	-6.18	-5.77	0.00
Operating Cash Flow to CapEx	706.69%	-67.77%	-13.56%	-620.00%	-2,278.41%	-6,182.03%	3,857.75%	-3,328.32%	-6,188.07%	-56,038.46%	-1,479.02%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.13	1.00	1.03	0.93	1.02	1.14	1.11	1.25	1.35	1.53	1.81
Accounts Receivable Turnover	5.46	4.74	4.78	4.65	5.03	4.72	5.55	7.15	8.01	7.68	6.92
Inventory Turnover	2.17	2.16	2.23	2.48	2.77	3.01	4.08	3.47	2.93	2.81	4.25
Fixed Asset Turnover	67.00	45.41	34.99	28.32	32.48	44.56	125.94	128.03	127.60	208.88	908.19
Accounts Payable Turnover	10.61	10.95	12.01	14.03	11.85	9.99	9.14	8.71	7.19	5.08	6.21
Days Sales Outstanding (DSO)	66.85	77.00	76.34	78.49	72.60	77.31	65.79	51.08	45.59	47.54	52.75
Days Inventory Outstanding (DIO)	168.14	169.28	163.98	147.06	132.00	121.40	89.44	105.22	124.54	129.67	85.96
Days Payable Outstanding (DPO)	34.40	33.32	30.40	26.01	30.79	36.55	39.93	41.91	50.73	71.86	58.76
Cash Conversion Cycle (CCC)	200.58	212.97	209.92	199.54	173.80	162.17	115.30	114.40	119.39	105.35	79.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	20	24	15	8.82	8.77	10	-0.55	3.31	2.49	2.45	2.63
Invested Capital Turnover	2.61	1.89	2.36	3.43	4.85	4.62	-97.47	41.34	17.90	19.72	20.04
Increase / (Decrease) in Invested Capital	8.02	3.26	-8.28	-6.60	-0.05	1.29	0.00	3.86	-0.82	-0.04	0.00
Enterprise Value (EV)	71	82	119	67	39	20	73	18	39	28	24
Market Capitalization	85	92	143	88	60	32	97	32	46	28	20
Book Value per Share	$3.43	$3.39	$3.86	$2.64	$2.20	$1.65	$1.47	$1.08	$0.59	$0.13	($0.06)
Tangible Book Value per Share	$3.34	$3.31	$3.79	$2.58	$2.16	$1.60	$1.27	$0.89	$0.43	($0.01)	($0.18)
Total Capital	34	34	39	31	30	23	23	17	9.52	4.84	8.66
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.74	3.74
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	3.74
Net Debt	-13	-10.00	-24	-22	-21	-13	-24	-14	-7.03	0.35	-2.29
Capital Expenditures (CapEx)	0.57	0.88	1.06	0.58	0.44	0.13	0.21	0.29	0.11	0.01	0.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	13	14	7.35	7.92	8.12	5.76	9.39	7.44	6.35	6.02
Debt-free Net Working Capital (DFNWC)	26	23	38	29	29	21	30	23	14	8.74	12
Net Working Capital (NWC)	26	23	38	29	29	21	30	23	14	7.00	12
Net Nonoperating Expense (NNE)	9.46	-0.00	9.92	3.85	3.81	2.53	-0.05	2.27	2.57	3.10	2.64
Net Nonoperating Obligations (NNO)	-13	-10.00	-24	-22	-21	-13	-24	-14	-7.03	0.35	-2.29
Total Depreciation and Amortization (D&A)	0.42	0.52	0.65	0.86	0.81	0.69	1.71	1.38	2.03	1.75	1.77
Debt-free, Cash-free Net Working Capital to Revenue	29.32%	31.95%	30.22%	17.68%	18.60%	18.69%	10.68%	16.48%	14.35%	13.05%	11.42%
Debt-free Net Working Capital to Revenue	60.39%	55.89%	81.67%	69.87%	68.35%	47.81%	54.93%	40.92%	27.91%	17.95%	22.86%
Net Working Capital to Revenue	60.39%	55.89%	81.67%	69.87%	68.35%	47.81%	54.93%	40.92%	27.91%	14.39%	22.86%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.01	$0.05	($1.15)	($1.11)	($1.05)	($0.64)	$0.00	($0.47)	($0.59)	($0.54)	($0.26)
Adjusted Weighted Average Basic Shares Outstanding	9.89M	9.96M	10.17M	11.56M	12.20M	13.71M	0.00	15.94M	16.13M	16.44M	16.93M
Adjusted Diluted Earnings per Share	$0.97	$0.05	($1.15)	($1.11)	($1.05)	($0.64)	$0.00	($0.47)	($0.59)	($0.54)	($0.26)
Adjusted Weighted Average Diluted Shares Outstanding	10.36M	10.13M	10.17M	11.56M	12.20M	13.71M	0.00	15.94M	16.13M	16.44M	16.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.86M	10.05M	11.52M	11.63M	13.63M	13.79M	0.00	16.01M	16.25M	16.79M	17.31M
Normalized Net Operating Profit after Tax (NOPAT)	1.81	0.20	-1.71	-9.12	-9.01	-6.28	-5.27	-5.28	-7.00	-5.81	-1.80
Normalized NOPAT Margin	4.23%	0.48%	-3.71%	-21.93%	-21.14%	-14.46%	-9.78%	-9.27%	-13.51%	-11.94%	-3.42%
Pre Tax Income Margin	3.11%	0.70%	-5.75%	-31.24%	-29.99%	-20.17%	-9.62%	-13.13%	-18.28%	-18.17%	-8.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	46.47%	329.75%	-0.50%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from IRIDEX's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	4/4/2026
DEI Shares Outstanding	16,229,103.00	16,247,813.00	16,252,813.00	16,252,948.00	16,509,412.00	16,636,380.00	16,789,027.00	16,789,027.00	16,992,253.00	17,307,401.00
DEI Adjusted Shares Outstanding	16,229,103.00	16,247,813.00	16,252,813.00	16,252,948.00	16,509,412.00	16,636,380.00	16,789,027.00	16,789,027.00	16,992,253.00	17,307,401.00
DEI Earnings Per Adjusted Shares Outstanding	-0.11	-0.18	-0.21	-0.16	-0.12	-0.05	-0.10	-0.06	-0.09	-0.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-12.20%	-18.01%	-14.19%	-1.74%	-9.88%	1.91%	1.15%	7.44%	7.80%	-0.82%
EBITDA Growth	-0.22%	-149.59%	-78.66%	-2.23%	-8.56%	87.48%	61.73%	75.38%	22.32%	94.47%
EBIT Growth	0.40%	-155.73%	-64.87%	3.48%	-9.74%	71.03%	51.14%	63.42%	18.11%	72.16%
NOPAT Growth	0.41%	-118.51%	-40.49%	8.85%	-10.78%	83.74%	93.77%	64.37%	24.55%	-58.05%
Net Income Growth	0.74%	-157.84%	-65.74%	3.15%	-10.21%	71.82%	51.33%	62.90%	18.62%	68.92%
EPS Growth	0.00%	-157.14%	-61.54%	5.88%	-9.09%	72.22%	52.38%	62.50%	25.00%	70.00%
Operating Cash Flow Growth	15.38%	38.43%	42.03%	-16.21%	-72.45%	-26.46%	30.28%	70.06%	62.32%	-16.19%
Free Cash Flow Firm Growth	16.59%	72.45%	125.33%	139.33%	141.14%	76.74%	-259.14%	-311.18%	-281.94%	62.31%
Invested Capital Growth	84.00%	-24.81%	-77.90%	-96.28%	-62.75%	-1.61%	204.21%	2,089.63%	84.94%	19.99%
Revenue Q/Q Growth	-0.04%	-3.05%	-5.59%	7.40%	-8.31%	9.63%	-6.30%	14.08%	-8.01%	0.00%
EBITDA Q/Q Growth	37.93%	-52.70%	-42.33%	24.21%	34.09%	82.38%	-334.96%	51.25%	-107.98%	0.00%
EBIT Q/Q Growth	36.65%	-66.09%	-18.14%	22.36%	27.97%	56.16%	-99.29%	41.88%	-61.25%	0.00%
NOPAT Q/Q Growth	41.67%	-82.52%	-6.88%	19.89%	29.11%	73.21%	59.08%	-358.54%	-50.11%	0.00%
Net Income Q/Q Growth	36.59%	-68.76%	-17.03%	22.66%	27.85%	56.85%	-102.16%	41.04%	-58.25%	0.00%
EPS Q/Q Growth	35.29%	-63.64%	-16.67%	23.81%	25.00%	58.33%	-100.00%	40.00%	-50.00%	0.00%
Operating Cash Flow Q/Q Growth	-56.18%	45.06%	-68.34%	19.54%	-131.75%	59.71%	7.19%	65.45%	-191.69%	0.00%
Free Cash Flow Firm Q/Q Growth	27.29%	56.14%	209.45%	12.69%	-23.94%	-124.80%	-648.79%	-49.54%	34.47%	0.00%
Invested Capital Q/Q Growth	12.51%	-39.06%	-57.03%	-87.37%	1,026.67%	60.95%	32.84%	-9.10%	-4.84%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.74%	39.21%	37.90%	40.65%	37.33%	44.00%	42.49%	34.50%	32.15%	40.18%
EBITDA Margin	-10.82%	-17.05%	-25.70%	-18.14%	-13.04%	-2.10%	-9.73%	-4.16%	-9.40%	-0.54%
Operating Margin	-13.14%	-24.73%	-28.00%	-20.89%	-16.15%	-3.95%	-1.72%	-6.93%	-11.30%	-2.75%
EBIT Margin	-13.59%	-23.28%	-29.13%	-21.06%	-16.54%	-6.62%	-14.07%	-7.17%	-12.57%	-3.95%
Profit (Net Income) Margin	-13.65%	-23.76%	-29.45%	-21.21%	-16.69%	-6.57%	-14.17%	-7.32%	-12.60%	-4.44%
Tax Burden Percent	100.46%	102.07%	101.11%	100.71%	100.89%	99.29%	100.72%	102.16%	100.25%	112.45%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-159.35%	-309.80%	-331.41%	-386.08%	-195.37%	-54.47%	-27.25%	-156.06%	-184.91%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-154.55%	-302.13%	-317.33%	-374.13%	-181.63%	-40.01%	6.96%	-146.74%	-145.50%	0.00%
Return on Net Nonoperating Assets (RNNOA)	122.23%	236.66%	233.58%	294.55%	112.32%	23.01%	-4.70%	102.73%	59.16%	0.00%
Return on Equity (ROE)	-37.12%	-73.13%	-97.83%	-91.53%	-83.04%	-31.46%	-31.95%	-53.33%	-125.75%	0.00%
Cash Return on Invested Capital (CROIC)	-244.34%	-213.35%	-132.17%	-212.33%	-180.42%	-233.85%	-269.97%	-341.78%	-158.37%	-18.17%
Operating Return on Assets (OROA)	-18.57%	-31.47%	-38.74%	-30.70%	-24.62%	-10.13%	-20.10%	-11.35%	-21.76%	0.00%
Return on Assets (ROA)	-18.66%	-32.12%	-39.17%	-30.92%	-24.83%	-10.06%	-20.25%	-11.60%	-21.81%	0.00%
Return on Common Equity (ROCE)	-37.12%	-73.13%	-97.83%	-91.53%	-83.04%	-31.46%	-17.58%	-22.28%	-22.45%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-64.31%	0.00%	-168.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-1.18	-2.16	-2.31	-1.85	-1.31	-0.35	-0.14	-0.66	-0.99	-0.23
NOPAT Margin	-9.20%	-17.31%	-19.60%	-14.62%	-11.30%	-2.76%	-1.21%	-4.85%	-7.91%	-1.92%
Net Nonoperating Expense Percent (NNEP)	-4.80%	-7.67%	-14.08%	-11.95%	-13.74%	-14.46%	-34.21%	-9.32%	-39.41%	-13.42%
Return On Investment Capital (ROIC_SIMPLE)	-	-22.65%	-35.53%	-43.49%	-24.33%	-7.25%	-3.19%	-6.76%	-11.78%	-2.67%
Cost of Revenue to Revenue	56.26%	60.79%	62.10%	59.35%	62.67%	56.00%	57.51%	65.50%	67.85%	59.82%
SG&A Expenses to Revenue	15.14%	19.30%	20.98%	22.05%	19.41%	17.92%	16.23%	16.33%	14.38%	13.76%
R&D to Revenue	11.99%	13.60%	13.06%	11.88%	11.22%	8.77%	7.36%	6.42%	7.79%	7.67%
Operating Expenses to Revenue	56.88%	63.94%	65.90%	61.54%	53.48%	47.94%	44.22%	41.43%	43.45%	42.93%
Earnings before Interest and Taxes (EBIT)	-1.75	-2.90	-3.43	-2.66	-1.92	-0.84	-1.67	-0.97	-1.57	-0.47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1.39	-2.12	-3.02	-2.29	-1.51	-0.27	-1.16	-0.56	-1.17	-0.06
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.42	4.79	7.47	8.27	11.27	13.25	19.69	250.41	0.00	0.00
Price to Tangible Book Value (P/TBV)	4.40	6.60	12.22	19.44	110.68	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.75	0.88	0.97	0.71	0.61	0.57	0.34	0.30	0.39	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.14	15.52	40.24	229.60	18.70	11.49	5.90	5.98	8.42	5.67
Enterprise Value to Revenue (EV/Rev)	0.61	0.74	0.86	0.62	0.59	0.58	0.39	0.36	0.47	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	1.05	1.31	0.53	0.61	0.79	0.80
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.55	0.48	0.53	0.61	0.79	0.80
Financial Leverage	-0.79	-0.78	-0.74	-0.79	-0.62	-0.58	-0.68	-0.70	-0.41	-0.38
Leverage Ratio	2.65	2.87	3.36	3.85	4.43	5.47	5.12	6.10	8.01	5.40
Compound Leverage Factor	2.65	2.87	3.36	3.85	4.43	5.47	5.12	6.10	8.01	5.40
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	51.25%	56.63%	34.72%	37.75%	44.18%	44.31%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	24.42%	35.86%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	26.84%	20.77%	34.72%	37.75%	44.18%	44.31%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	61.64%	71.55%	70.61%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	57.16%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	48.75%	43.37%	8.12%	0.61%	-15.73%	-14.92%
Debt to EBITDA	0.00	0.00	0.00	0.00	-0.31	-0.39	-0.70	-1.05	-1.17	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.12	-0.05	0.69	0.89	0.59	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	-0.16	-0.14	-0.70	-1.05	-1.17	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	-0.36	-0.47	-1.00	-1.49	-1.73	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.14	-0.06	0.99	1.26	0.87	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	-0.19	-0.17	-1.00	-1.49	-1.73	0.00
Altman Z-Score	0.01	-0.38	-0.80	-1.39	-1.67	-1.75	-1.54	-1.70	-1.96	-3.73
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	44.98%	58.22%	82.15%	103.59%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.64	2.12	1.72	1.55	1.54	1.42	1.95	1.96	1.94	1.92
Quick Ratio	1.36	1.06	0.74	0.64	0.62	0.50	0.93	1.02	1.03	0.89
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3.05	-1.34	1.46	1.65	1.25	-0.31	-2.33	-3.48	-2.28	-0.88
Operating Cash Flow to CapEx	-2,173.17%	0.00%	-54,933.33%	0.00%	-307,300.00%	-13,755.56%	-10,445.45%	-3,053.85%	-8,907.69%	-1,321.78%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.37	1.35	1.33	1.46	1.49	1.53	1.43	1.58	1.73	0.00
Accounts Receivable Turnover	6.89	8.01	5.78	7.84	8.03	7.68	7.39	7.42	7.74	0.00
Inventory Turnover	2.97	2.93	2.66	2.66	2.81	2.81	2.72	3.08	3.43	0.00
Fixed Asset Turnover	113.88	127.60	139.84	164.03	142.23	208.88	287.08	399.55	562.74	0.00
Accounts Payable Turnover	8.56	7.19	5.22	4.97	6.73	5.08	4.18	4.60	5.90	0.00
Days Sales Outstanding (DSO)	52.98	45.59	63.18	46.58	45.46	47.54	49.38	49.18	47.15	0.00
Days Inventory Outstanding (DIO)	122.86	124.54	137.16	137.20	129.71	129.67	134.44	118.60	106.33	0.00
Days Payable Outstanding (DPO)	42.65	50.73	69.99	73.44	54.27	71.86	87.29	79.32	61.84	0.00
Cash Conversion Cycle (CCC)	133.19	119.39	130.36	110.35	120.90	105.35	96.53	88.46	91.64	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4.08	2.49	1.07	0.14	1.52	2.45	3.25	2.96	2.81	3.90
Invested Capital Turnover	17.33	17.90	16.91	26.41	17.28	19.72	22.59	32.19	23.37	0.00
Increase / (Decrease) in Invested Capital	1.86	-0.82	-3.77	-3.49	-2.56	-0.04	2.18	2.82	1.29	0.65
Enterprise Value (EV)	33	39	43	31	28	28	19	18	24	22
Market Capitalization	41	46	48	35	30	28	17	15	20	17
Book Value per Share	$0.74	$0.59	$0.40	$0.26	$0.16	$0.13	$0.05	$0.00	($0.08)	($0.07)
Tangible Book Value per Share	$0.58	$0.43	$0.24	$0.11	$0.02	($0.01)	($0.08)	($0.12)	($0.20)	($0.18)
Total Capital	12	9.52	6.49	4.25	5.38	4.84	10	9.73	8.39	8.50
Total Debt	0.00	0.00	0.00	0.00	2.76	2.74	3.64	3.68	3.71	3.77
Total Long-Term Debt	0.00	0.00	0.00	0.00	1.44	1.00	3.64	3.68	3.71	3.77
Net Debt	-7.98	-7.03	-5.42	-4.11	-1.10	0.35	-3.60	-3.10	-1.87	-0.83
Capital Expenditures (CapEx)	0.08	-0.03	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	9.01	7.44	6.09	4.75	5.94	6.35	6.94	6.38	6.10	7.16
Debt-free Net Working Capital (DFNWC)	17	14	12	8.86	9.80	8.74	14	13	12	12
Net Working Capital (NWC)	17	14	12	8.86	8.49	7.00	14	13	12	12
Net Nonoperating Expense (NNE)	0.57	0.80	1.16	0.83	0.62	0.48	1.54	0.34	0.59	0.30
Net Nonoperating Obligations (NNO)	-7.98	-7.03	-5.42	-4.11	-1.10	0.35	-3.60	-3.10	-1.87	-0.83
Total Depreciation and Amortization (D&A)	0.36	0.78	0.40	0.37	0.41	0.57	0.52	0.41	0.40	0.40
Debt-free, Cash-free Net Working Capital to Revenue	16.51%	14.35%	12.20%	9.56%	12.26%	13.05%	14.22%	12.83%	12.05%	0.00%
Debt-free Net Working Capital to Revenue	31.12%	27.91%	23.06%	17.83%	20.23%	17.95%	29.06%	26.45%	23.05%	0.00%
Net Working Capital to Revenue	31.12%	27.91%	23.06%	17.83%	17.52%	14.39%	29.06%	26.45%	23.05%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.11)	($0.18)	($0.21)	($0.16)	($0.12)	($0.05)	($0.10)	($0.06)	($0.09)	($0.03)
Adjusted Weighted Average Basic Shares Outstanding	16.23M	16.13M	16.25M	16.29M	16.58M	16.44M	16.73M	16.79M	17.01M	17.31M
Adjusted Diluted Earnings per Share	($0.11)	($0.18)	($0.21)	($0.16)	($0.12)	($0.05)	($0.10)	($0.06)	($0.09)	($0.03)
Adjusted Weighted Average Diluted Shares Outstanding	16.23M	16.13M	16.25M	16.29M	16.58M	16.44M	16.73M	16.79M	17.01M	17.31M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	16.25M	16.25M	16.25M	16.51M	16.64M	16.79M	16.79M	16.99M	17.19M	17.41M
Normalized Net Operating Profit after Tax (NOPAT)	-1.18	-2.16	-2.31	-1.85	-1.31	-0.35	-0.14	-0.66	-0.99	-0.23
Normalized NOPAT Margin	-9.20%	-17.31%	-19.60%	-14.62%	-11.30%	-2.76%	-1.21%	-4.85%	-7.91%	-1.92%
Pre Tax Income Margin	-13.59%	-23.28%	-29.13%	-21.06%	-16.54%	-6.62%	-14.07%	-7.17%	-12.57%	-3.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

IRIDEX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IRIDEX's financial year ends in January. Their financial year 2026 ended on January 3, 2026.

IRIDEX's net income appears to be on an upward trend, with a most recent value of -$4.44 million in 2026, falling from $10.04 million in 2014. The previous period was -$8.91 million in 2024. Find out what analysts predict for IRIDEX in the coming months.

IRIDEX's total operating income in 2026 was -$2.57 million, based on the following breakdown:

Total Gross Profit: $19.23 million
Total Operating Expenses: $21.80 million

Over the last 10 years, IRIDEX's total revenue changed from $42.81 million in 2014 to $52.68 million in 2026, a change of 23.0%.

IRIDEX's total liabilities were at $24.23 million at the end of 2026, a 10.4% decrease from 2024, and a 199.8% increase since 2014.

In the past 10 years, IRIDEX's cash and equivalents has ranged from $2.39 million in 2024 to $23.85 million in 2021, and is currently $6.03 million as of their latest financial filing in 2026.

Over the last 10 years, IRIDEX's book value per share changed from 3.43 in 2014 to -0.06 in 2026, a change of -101.8%.

Related Companies

Financial statements for NASDAQ:IRIX last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Financials

Financials Breakdown Chart

IRIDEX Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Financials

Annual Income Statements for IRIDEX

Quarterly Income Statements for IRIDEX

Annual Cash Flow Statements for IRIDEX

Quarterly Cash Flow Statements for IRIDEX

Annual Balance Sheets for IRIDEX

Quarterly Balance Sheets for IRIDEX

Annual Metrics And Ratios for IRIDEX

Quarterly Metrics And Ratios for IRIDEX

Financials Breakdown Chart

IRIDEX Financials - Frequently Asked Questions

When does IRIDEX's fiscal year end?

How has IRIDEX's net income changed over the last 10 years?

What is IRIDEX's operating income?

How has IRIDEX's revenue changed over the last 10 years?

How much debt does IRIDEX have?

How much cash does IRIDEX have?

How has IRIDEX's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools